# Metabolomic profiling of skeletal muscle in GSDMD-knockout mice reveals distinct metabolic alterations in sepsis-induced myopathy

**Authors:** Yongsheng Zhang, Qinxin Liu, Ligang Xu, Dongfang Wang, Xiangjun Bai, Zhanfei Li, Yukun Liu, Yuchang Wang

PMC · DOI: 10.1515/med-2025-1311 · Open Medicine · 2026-02-24

## TL;DR

This study shows that removing GSDMD in mice changes skeletal muscle metabolism during sepsis, potentially offering new ways to diagnose and treat sepsis-related muscle damage.

## Contribution

The study reveals novel metabolic pathways influenced by GSDMD deficiency in sepsis-induced skeletal muscle changes.

## Key findings

- GSDMD deficiency alters taurine, amino acid, and bile acid metabolism in skeletal muscle during sepsis.
- Metabolic changes suggest GSDMD regulates energy, lipid, and redox metabolism in sepsis.
- Potential biomarkers for muscle injury and repair were identified in GSDMD-knockout mice.

## Abstract

Gasdermin D (GSDMD), a key pyroptosis effector, is implicated in systemic inflammation during sepsis. However, its role in skeletal muscle metabolism remains largely unexplored.

GSDMD-knockout (GSDMD-KO) and wild-type (WT) mice were used to establish a septic model. Skeletal muscle samples were collected and subjected to non-targeted metabolomic analysis via UHPLC-QE-MS. Multivariate statistical analysis and KEGG pathway enrichment were performed to identify differential metabolites and explore the underlying metabolic alterations.

GSDMD knockout resulted in significant changes in skeletal muscle metabolism, notably in pathways related to taurine and hypotaurine metabolism, amino acid biosynthesis, bile acid biosynthesis, oxidative stress response, and nucleotide metabolism. These alterations suggest that GSDMD regulates energy, amino acid, lipid, and redox metabolism during sepsis. A panel of potential biomarkers was identified, which may contribute to muscle injury and repair.

GSDMD deficiency profoundly alters skeletal muscle metabolic profiles in sepsis. Identified metabolites may serve as diagnostic markers and therapeutic targets for sepsis-associated myopathy, offering insights into GSDMD’s role in muscle metabolism and potential intervention strategies.

## Linked entities

- **Genes:** GSDMD (gasdermin D) [NCBI Gene 79792]
- **Chemicals:** taurine (PubChem CID 1123), hypotaurine (PubChem CID 107812), bile acid (PubChem CID 439520)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}, Xdh (xanthine dehydrogenase) [NCBI Gene 22436] {aka XO, Xor, Xox-1, Xox1}, Vip (vasoactive intestinal polypeptide) [NCBI Gene 22353], Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** septic (MESH:D001170), Sepsis (MESH:D018805), CLP (MESH:D002429), liver damage (MESH:D056486), muscle dysfunction (MESH:D009135), coagulation disorders (MESH:D001778), metabolic disease (MESH:D008659), multi-organ failure (MESH:D009102), microbial (MESH:D015163), GSDMD deficiency (MESH:D014808), cancer (MESH:D009369), atrophy (MESH:D001284), lung injury (MESH:D055370), muscle atrophy (MESH:D009133), inflammation (MESH:D007249)
- **Chemicals:** Lysine (MESH:D008239), Sphingolipid (MESH:D013107), guanosine (MESH:D006151), glucose (MESH:D005947), calcium (MESH:D002118), reactive oxygen species (MESH:D017382), Taurine (MESH:D013654), Methylsuccinic acid (MESH:C039138), Glutathione (MESH:D005978), Citrate (MESH:D019343), Gln (MESH:D005973), LPS (MESH:D008070), Lipids (MESH:D008055), Cysteine (MESH:D003545), endocannabinoid (MESH:D063388), purine (MESH:C030985), Amino acids (MESH:D000596), TCA (MESH:D014238), L-Iditol (MESH:C082913), d-Alanine (-), hypotaurine (MESH:C003949), sulfur (MESH:D013455), bile acid (MESH:D001647), Pyroglutamic acid (MESH:D011761), Xanthine (MESH:D019820), Pyrimidine (MESH:C030986), leucine (MESH:D007930), water (MESH:D014867), Valine (MESH:D014633), Uracil (MESH:D014498), choline (MESH:D002794), isoleucine (MESH:D007532), acetonitrile (MESH:C032159), inosine (MESH:D007288), methionine (MESH:D008715), Succinic acid (MESH:D019802), methanol (MESH:D000432), saline (MESH:D012965), Glycerophospholipid (MESH:D020404), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927549/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927549/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927549/full.md

---
Source: https://tomesphere.com/paper/PMC12927549